Table 5.
Post Hoc Tukey test for pairwise comparison of factors affecting toluidine blue staining percentage area
| Time of assessment | Control | Arthritis | Secretome + LLLT | ADSCs + LLLT |
|---|---|---|---|---|
| 1 Week | 25.16 ± 3.22 | 4.29 ± 0.25 | 14.11 ± 1.85 | 17.57 ± 2.70 |
| P1 < 0.0001* |
P1 < 0.0001* P2 < 0.0001* |
P1 = 0.0002* P2 < 0.0001* P3 = 0.2924 |
||
| 3 Week | 25.55 ± 4.26 | 7.62 ± 0.65 | 18.47 ± 1.86 | 20.71 ± 2.96 |
| P4 > 0.9999 |
P1 < 0.0001* P4 = 0.3392 |
P1 = 0.0005* P2 < 0.0001* P4 = 0.0871 |
P1 = 0.0396* P2 < 0.0001* P3 = 0.7877 P4 = 0.4104 |
P Probability, *significance < 0.05, P1: significance Vs control group, P2: significance Vs arthritis group, P3: significance Vs secretome/LLLT group, P4: Significance Vs 1 week group within the same intervention